Zielinski, R. R., A. A. Azad, K. N. Chi, and S. Tyldesley. “Population-Based Impact on Overall Survival After the Introduction of Docetaxel As Standard Therapy for Metastatic Castration Resistant Prostate Cancer”. Canadian Urological Association Journal, vol. 8, no. 7-8, Aug. 2014, pp. e520-3, doi:10.5489/cuaj.2076.